Should you be able to buy a kidney (and for how much )? | FT #shorts

Key Concepts

• Kidney Transplantation: A surgical procedure to replace a failing kidney with a healthy one from a donor.
• Dialysis: A medical process for removing waste and excess water from the blood, used as a treatment for kidney failure.
• Clearing Price: The economic price at which the supply of a good or service matches the demand.
• Living Kidney Donation: The act of a living person donating one of their two kidneys for transplantation.
• Healthcare Economics: The study of how resources are allocated within the healthcare system to maximize efficiency and patient outcomes.

---

The Case for a Regulated Kidney Market

The speaker advocates for the creation of a legal, ethical, and equitable market for living kidney donors to address the critical shortage of organs available for transplantation. The core argument is that the current system, which relies on altruistic donation, is insufficient to meet the demand, leading to preventable deaths.

Economic Rationale and Cost-Benefit Analysis

The proposal is grounded in the significant financial disparity between the cost of dialysis and the cost of transplantation:

• Dialysis Costs: The United States Medicare system spends approximately $55 billion annually on kidney failure, the vast majority of which is allocated to dialysis treatments.
• Transplant Efficiency: A kidney transplant costs roughly the same as one year of dialysis. However, while a transplant provides a long-term solution, dialysis is a recurring, lifelong expense.
• Proposed Compensation: The speaker suggests that the government or healthcare system could afford to pay donors between $80,000 and $100,000 per kidney. This figure is estimated to be above the "clearing price" (the price required to incentivize enough donors to meet demand) while still resulting in a net reduction in total healthcare spending.

Addressing Ethical and Practical Concerns

The speaker acknowledges that implementing a market for organs involves complex ethical and legal challenges. However, they maintain that these issues are "manageable." The framework for such a market would need to:

1. Prevent Exploitation: Ensure that the system does not prey on vulnerable populations.
2. Ensure Equity: Design the market so that access to kidneys is not restricted solely to the wealthy, maintaining fairness in the distribution of organs.
3. Legalization: Transition from the current prohibition of organ sales to a regulated, state-sanctioned model.

Global Impact

While the focus is on the United States healthcare system, the speaker notes that the implications are global. If a successful model for a regulated kidney market were established, it could be scaled to other countries, potentially saving millions of lives worldwide.

Conclusion

The primary takeaway is that the current reliance on altruism for kidney donation is failing to address the organ shortage. By shifting to a regulated market where donors are generously compensated, the healthcare system could simultaneously improve patient outcomes—by replacing inferior dialysis treatments with superior transplants—and achieve massive cost savings for taxpayers. The speaker posits that the financial savings from reducing dialysis dependency provide a clear economic justification for incentivizing living donation.